Trials / Conditions / Pancreatic Insufficiency

Pancreatic Insufficiency

25 registered clinical trials studyying Pancreatic Insufficiency — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Breath Test-Based Assessment of SIBO in Chronic Pancreatitis and Partial Pancreatectomy NCT07479238	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Recruiting	Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis NCT06995651	University of Pennsylvania	Phase 1
Active Not Recruiting	PERT to Improve Quality of Life in Patients Undergoing Pancreaticoduodenectomy: A Pilot Randomized Controlled NCT05466838	Sunnybrook Health Sciences Centre	N/A
Recruiting	GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance NCT04731272	University of Pennsylvania	Phase 2
Completed	Hypoglycemia and Glucagon Response in CF NCT05700604	Marmara University	—
Completed	Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency NCT03551691	Children's Hospital of Philadelphia	Phase 2
Unknown	Pancreatic Exocrine Insufficiency After Bariatric Surgery NCT03279653	Umraniye Education and Research Hospital	—
Unknown	Equivalence Study to Compare Two Strengths of Creon in China NCT03450772	Abbott	Phase 3
Completed	MRI to Characterize and Predict CF Liver Disease in PUSH Cohort NCT02979340	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	—
Terminated	PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer NCT02985801	Massimo Raimondo, M.D.	Phase 1 / Phase 2
Completed	Effect of Chronic Incretin-based Therapy in Cystic Fibrosis NCT01879228	University of Pennsylvania	N/A
Completed	Pancreatic Insufficiency Secondary to Tobacco Exposure NCT01988350	Emory University	—
Recruiting	Beta-cell Response to Incretin Hormones in Cystic Fibrosis NCT01851694	University of Pennsylvania	N/A
Completed	Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis NCT01710644	Nordmark Arzneimittel GmbH & Co. KG	Phase 1 / Phase 2
Unknown	Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutica NCT01012908	Azidus Brasil	Phase 2 / Phase 3
Completed	Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis NCT01144507	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	—
Completed	Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF) NCT00880100	Forest Laboratories	Phase 3
Completed	Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis NCT00705978	Abbott Products	Phase 3
Completed	Creon After Pancreatic Surgery NCT00535756	Abbott Products	Phase 4
Completed	Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cys NCT00513682	Forest Laboratories	Phase 3
Completed	Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis NCT00432861	Digestive Care, Inc.	Phase 3
Completed	Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI NCT00406536	Avanti Polar Lipids, Inc.	Phase 2
Completed	Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis NCT00763412	Arbelaez, Ana Maria	N/A
Completed	Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea NCT00572975	Children's Hospital of Philadelphia	Phase 4
Completed	Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency NCT00095732	Anthera Pharmaceuticals	Phase 2